There are 2789 resources available
Panel discussion: what outcomes should we expect in early stage NSCLC: the importance of targeting the right patients with the right treatment
Presenter: Helena A. Yu
Session: AstraZeneca - Osimertinib in early- and late-stage NSCLC: Breaking new ground in EGFRm disease
Resources:
Webcast
Shaping first-line clinical practice with third-generation EGFR-TKIs in patients with metastatic EGFRm NSCLC
Presenter: Helena A. Yu
Session: AstraZeneca - Osimertinib in early- and late-stage NSCLC: Breaking new ground in EGFRm disease
Resources:
Webcast
Panel discussion: Learnings from real-world practice in first-line metastatic EGFRm NSCLC
Presenter: Helena A. Yu
Session: AstraZeneca - Osimertinib in early- and late-stage NSCLC: Breaking new ground in EGFRm disease
Resources:
Webcast
Meeting close
Presenter: Egbert F. Smit
Session: AstraZeneca - Osimertinib in early- and late-stage NSCLC: Breaking new ground in EGFRm disease
Resources:
Webcast
Is a one size fits all approach still appropriate for NSCLS with an EGFR mutation, are all mutations equal?
Presenter: Joachim Aerts
Session: Lilly - Personalising and optimising treatment for metastatic NSCLC patients with EGFR and other co-occurring mutations
Resources:
Webcast
Scientific rationale for dual inhibition of VEGF and EGFR
Presenter: Nobuyuki Takakura
Session: Lilly - Personalising and optimising treatment for metastatic NSCLC patients with EGFR and other co-occurring mutations
Resources:
Webcast
Identifying the clinical and disease characteristics of the high risk patient, what is the science telling us?
Presenter: Federico Cappuzzo
Session: Lilly - Personalising and optimising treatment for metastatic NSCLC patients with EGFR and other co-occurring mutations
Resources:
Webcast
Case study from the clinic – Potential patient profile and include sequencing and discuss with panel
Presenter: Chao-Hua Chiu
Session: Lilly - Personalising and optimising treatment for metastatic NSCLC patients with EGFR and other co-occurring mutations
Resources:
Webcast
NSCLC, metastatic 1
Presenter: Edward Garon
Session: Expert selection 2
Resources:
Slides
Webcast
GI, colorectal
Presenter: Julien Taieb
Session: Expert selection 2
Resources:
Slides
Webcast